In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials?

Featured Guests:

• Laurie, Breast Cancer Clinical Trial Participant
• Dr. Edith Mitchell, Medical Oncologist, Thomas Jefferson University
• Julia Perkins Smith, Global Clinical Lead, Pfizer
• Jamil Rivers, CEO, Chrysalis Initiative

Additional Resources:

• pfizerclinicaltrials.com/oncology
• pfizerclinicaltrials.com
• pfizerestudiosclinicos.com

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.